Académique Documents
Professionnel Documents
Culture Documents
Piramal Pharma delivery model has a proven track record of providing a step change in the
effectiveness of drug discovery and development process for a range of global
pharmaceuticals and biotechnology companies operating at the forefront of drug discovery.
We understand that early and intensive evaluation of the molecules based on thorough
communications and rapid decision-making will lead to a high throughput of successful druglike compounds.
The model has been designed for speed and revolves around effective project management,
processes/equipment and people. The effectiveness of the operations in India is boosted by
the UK project office (Cambridge) which provides logistical, communications and objective
project management support.
IP/IT Security
At Piramal Pharma Solutions, we understand the responsibility to protect the IP of clients. Our
IP security model is designed to protect IP during the project lifecycle and beyond. Key steps
taken in this regard are:
CDA signed with all employees (if required CDAs can be executed directly between
clients and project teams at PDS)
Upfront patent assignment on MSAs
Mandatory Checks to ensure adherence to IP Process
Piramal Drug Discovery and Development Solutions (PDS) offers a comprehensive range of
Contract Research Services from our state-of-the-art research centre in India to support drug
discovery activities. We started building our expertise supporting start-ups and virtual biotech
companies but have subsequently expanded our offering to serve Pharma, Biotech, and
Academia, over the last 10 years. Our world class chemistry laboratories located in
Ahmedabad, India, has 300+ scientists. At Piramal Discovery Solutions, we understand the
entrepreneurial and emerging biotech culture which empowers us to deliver creative and
flexible solutions in a timely manner to our customers.
Our discovery services are forward integrated with our API and Formulation services, thus
allowing us to serve our customers across the drug value chain.